share_log

EV Biologics Briefs Shareholders on Market Cap Peer Comparison

EV Biologics Briefs Shareholders on Market Cap Peer Comparison

EV Biologics向股东介绍市值同行比较
accesswire ·  2021/08/12 01:00

Published: 08/12/2021YECO

发布日期:08/12/2021YECO

NASHVILLE, TN / ACCESSWIRE / August 12, 2021 / EV Biologics Corp, OTC Pink:YECO, today briefed shareholders on its current value compared to other public biotechnology companies in its peer group.

田纳西州纳什维尔/ACCESSWIRE/2021年8月12日/EV Biologics Corp(场外交易市场代码:YECO)今天向股东简要介绍了与其同行中的其他上市生物技术公司相比,该公司目前的价值。

Please view the chart at:https://www.evbiologics.com/marketcap/.

请浏览图表:https://www.evbiologics.com/marketcap/.

CEO Daniel Mckinney commented: 'Our market cap is less than half that of our closest listed peer. Our goal is to continue to build value and become the largest listed company by market cap in our space within the next 24 months. This...

首席执行官丹尼尔·麦金尼(Daniel McKinney)评论说:“我们的市值不到最接近的上市同行的一半。我们的目标是继续创造价值,并在未来24个月内成为我们领域市值最大的上市公司。这……

20210812220338264d1977ysav4rdiy6

Read more: EV Biologics Corporation

阅读更多内容:EV生物制品公司

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发